Download Handouts: https://bit.ly/48Q3kWG

Are you curious about the latest advancements in the sublingual delivery of semaglutide? Join us for an insightful and informative FREE webinar led by PCCA Chief Scientific Officer Gus Bassani, PharmD, PCCA Director of Research & Development Daniel Banov, MS, RPh, and PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh.

What you’ll learn:
Latest Findings: Discover groundbreaking pharmacokinetic study results highlighting the advantages of sublingual delivery, including less variability in blood levels and improved bioavailability.

Effective Dosing Strategies: Receive practical guidance on dosing strategies and formulations designed for optimal patient outcomes.

Weight Management Support: Explore supplements that complement semaglutide for effective weight management.

Beyond Semaglutide: Gain insights into additional applications of SubMagna™ SL HMW technology beyond semaglutide.